XML 34 R22.htm IDEA: XBRL DOCUMENT v3.4.0.3
Equity Compensation (Tables)
3 Months Ended
Mar. 31, 2016
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Stock-Based Compensation Expense and Related Income Tax Benefit

The amount of stock-based compensation expense and the line items in which those amounts are included in our Condensed Consolidated Statements of Operations and the related estimated income tax benefit recognized in the periods indicated were as follows:

 

     Three Months Ended
March 31,
 
     2016      2015  

Cost of educational services

   $ 708       $ 942   

Student services and administrative expenses

     519         954   
  

 

 

    

 

 

 

Total stock-based compensation expense

   $ 1,227       $ 1,896   

Income tax (benefit)

   $ (472    $ (730
Stock Options Granted, Forfeited, Exercised and Expired

The stock options granted, forfeited, exercised and expired in the period indicated were as follows:

 

     Three Months Ended March 31, 2016  
     # of
Shares
    Weighted
Average
Exercise
Price
     Aggregate
Exercise
Price
    Weighted
Average
Remaining
Contractual Term
     Aggregate
Intrinsic
Value (1)
 

Outstanding at beginning of period

     1,088,208      $ 70.21       $ 76,405        

Granted

     159,000      $ 3.57         568        

Forfeited

     0      $ 0         0        

Exercised

     0      $ 0         0        

Expired

     (188,500   $ 121.56         (22,914     
  

 

 

      

 

 

      

Outstanding at end of period

     1,058,708      $ 51.06       $ 54,059        1.9       $ 0   
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

Exercisable at end of period

     736,061      $ 69.17       $ 50,913        1.7       $ 0   
  

 

 

   

 

 

    

 

 

   

 

 

    

 

 

 

 

(1) The aggregate intrinsic value of the stock options was calculated by identifying those stock options that had a lower exercise price than the closing market price of our common stock on March 31, 2016 and multiplying the difference between the closing market price of our common stock and the exercise price of each of those stock options by the number of shares subject to those stock options that were outstanding or exercisable, as applicable. Since the closing market price of our common stock on March 31, 2016 was lower than the exercise price of all outstanding stock options and exercisable stock options, the aggregate intrinsic value of the stock options was zero.
Stock Options Granted and Exercised

The following table sets forth information regarding the stock options granted and exercised in the periods indicated:

 

     Three Months Ended
March 31,
 
     2016      2015  

Shares subject to stock options granted

     159,000         0   

Weighted average grant date fair value per share

   $ 2.09       $ 0   

Shares subject to stock options exercised

     0         0   

Intrinsic value of stock options exercised

   $ 0       $ 0   

Proceeds received from stock options exercised

   $ 0       $ 0   

Tax benefits realized from stock options exercised

   $ 0       $ 0   
Assumptions used to Estimate Grant Date Fair Value of Stock Options

The fair value of each stock option grant was estimated on the date of grant using the following assumptions in the periods indicated:

 

     Three Months Ended
March 31,
     2016     2015

Risk-free interest rates

     1.3   Not applicable

Expected lives (in years)

     4.8      Not applicable

Volatility

     75.0   Not applicable

Dividend yield

     None      Not applicable
Number of Restricted Stock Units (RSUs) Granted, Forfeited and Vested

The following table sets forth the number of restricted stock units (“RSUs”) that were granted, forfeited and vested in the period indicated:

 

     Three Months Ended
March 31, 2016
 
     # of RSUs      Weighted Average
Grant Date

Fair Value
 

Unvested at beginning of period

     793,019       $ 14.18   

Granted

     411,224         3.56   

Forfeited

     (47,837      10.21   

Vested

     (37,350      18.23   
  

 

 

    

Unvested at end of period

     1,119,056       $ 10.31